EXTRACTION, GEL-FILTRATION PATTERN, AND RECEPTOR-BINDING OF PORCINE GASTROINTESTINAL GLUCAGON-LIKE IMMUNOREACTIVITY

被引：60
|
作者：
HOLST, JJ [1 ]
机构：
[1] BISPEBJERG HOSP,DEPT CLIN CHEM,DK-2400 COPENHAGEN NV,DENMARK
来源：
DIABETOLOGIA | 1977年 / 13卷 / 02期
关键词：
D O I：
10.1007/BF00745145
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：159 / 169
页数：11
相关论文
共 50 条
  • [21] Anesthetic Considerations in Adult Patients on Glucagon-Like Peptide-1 Receptor Agonists: Gastrointestinal Focus
    Joshi, Girish P.
    ANESTHESIA AND ANALGESIA, 2024, 138 (01): : 216 - 220
  • [22] Association between Glucagon-Like Peptide-1 Receptor Agonist Use and Estimated Glomerular Filtration Rate
    Lage, Maureen J.
    Botros, Fady T.
    Haupt, Axel
    Woodward, Brad
    Boye, Kristina S.
    DIABETES, 2017, 66 : A290 - A291
  • [23] INSULIN-LIKE GROWTH-FACTOR - MODEL FOR TERTIARY STRUCTURE ACCOUNTING FOR IMMUNOREACTIVITY AND RECEPTOR-BINDING
    BLUNDELL, TL
    BEDARKAR, S
    RINDERKNECHT, E
    HUMBEL, RE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) : 180 - 184
  • [24] Does pancreatic immunoreactivity of glucagon-like peptide and its receptor differ between infants with hyperinsulinism of infancy and control infants?
    Greer, Ristan M.
    Loo, Suet Wern
    Walker, Rosslyn M.
    Bowlay, Gregory
    Venter, Deon J.
    Cotterill, Andrew M.
    HORMONE RESEARCH, 2009, 72 : 339 - 339
  • [25] Modularity in receptor evolution: insulin- and glucagon-like peptide modules as binding sites for insulin and glucose in the insulin receptor
    Root-Bernstein, Robert
    Vonck, Jessica
    JOURNAL OF RECEPTOR LIGAND AND CHANNEL RESEARCH, 2010, 3 : 87 - 96
  • [26] Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
    Sodhi, Mohit
    Rezaeianzadeh, Ramin
    Kezouh, Abbas
    Etminan, Mahyar
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (18): : 1795 - 1797
  • [27] Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists
    Jalleh, Ryan J.
    Jones, Karen L.
    Nauck, Michael
    Horowitz, Michael
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (11) : 1542 - 1543
  • [28] Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences
    Horowitz, Michael
    Aroda, Vanita R.
    Han, Jenny
    Hardy, Elise
    Rayner, Chris K.
    DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 672 - 681
  • [29] Treatment of obesity with medications binding the glucagon-like peptide 1 receptor: what is the current state of play?
    Le Roux, Carel
    Mondoh, Alvin
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (02) : 131 - 138
  • [30] Sulfonylurea Receptor 1, Glucagon-Like Peptide Receptor 1, and Adrenergic Receptor Alpha 2A are Expressed and Functional in Adult Porcine Islets
    Kelly, Amy
    Penrod, Leah
    Anderson, Miranda
    Kitzmann, Jennifer
    Hart, Nathaniel
    Lynch, Ronald
    Limesand, Sean
    Papas, Klearchos
    TRANSPLANTATION, 2013, 96 (06) : S152 - S152
12345